HCW Biologics
Stock Forecast, Prediction & Price Target
HCW Biologics Financial Estimates
HCW Biologics Revenue Estimates
HCW Biologics EBITDA Estimates
HCW Biologics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $6.72M 0% | $2.84M -57.72% | Avg: $1.6M Low: $1.6M High: $1.6M avg. -43.69% | Avg: $900K Low: $900K High: $900K avg. -43.75% | Avg: $33.73M Low: $33.73M High: $33.73M avg. 3647.77% | Avg: $57.14M Low: $57.14M High: $57.14M avg. 69.43% |
Net Income
% change YoY
| $-12.35M N/A | $-14.72M -19.14% | $-24.99M -69.76% | Avg: $-29.59M Low: $-19.76M High: $-19.76M avg. -18.42% | Avg: $-38.47M Low: $-22.63M High: $-22.63M avg. -29.99% | Avg: $-24.79M Low: $-24.79M High: $-24.79M avg. 35.57% | Avg: $-9.70M Low: $-9.70M High: $-9.70M avg. 60.86% |
EBITDA
% change YoY
| $-12.82M N/A | $-14.77M -15.20% | $-23.57M -59.57% | Avg: $-319.99K Low: $-319.99K High: $-319.99K avg. 98.64% | Avg: $-179.99K Low: $-179.99K High: $-179.99K avg. 43.75% | Avg: $-6.74M Low: $-6.74M High: $-6.74M avg. -3647.79% | Avg: $-11.42M Low: $-11.42M High: $-11.42M avg. -69.43% |
EPS
% change YoY
| -$0.35 N/A | -$0.41 -17.14% | -$0.7 -70.73% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 21.42% | Avg: -$0.63 Low: -$0.63 High: -$0.63 avg. -14.54% | Avg: -$0.69 Low: -$0.69 High: -$0.69 avg. -9.52% | Avg: -$0.27 Low: -$0.27 High: -$0.27 avg. 60.86% |
Operating Expenses
% change YoY
| $13.36M N/A | $17.66M 32.14% | $26.27M 48.75% | Avg: $3.25M Low: $3.25M High: $3.25M avg. -87.61% | Avg: $1.83M Low: $1.83M High: $1.83M avg. -43.75% | Avg: $68.60M Low: $68.60M High: $68.60M avg. 3647.77% | Avg: $116.23M Low: $116.23M High: $116.23M avg. 69.43% |
FAQ
What is HCW Biologics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 12.00% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -19.76M, average is -29.59M and high is -19.76M.
What is HCW Biologics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 907.44% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $1.6M, average is $1.6M and high is $1.6M.
What is HCW Biologics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 14.55% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.55, average is -$0.55 and high is $-0.55.